Life (Jun 2022)

Vulvovaginal <i>Candida</i> <i>albicans</i> Clinical Isolates’ Resistance to Phagocytosis In-Vitro

  • Paula Faria-Gonçalves,
  • Ana Sofia Oliveira,
  • Carlos Gaspar,
  • Lisa Rodrigues,
  • Rita Palmeira-de-Oliveira,
  • José Martinez-de-Oliveira,
  • Teresa Gonçalves,
  • Ana Palmeira-de-Oliveira,
  • Joana Rolo

DOI
https://doi.org/10.3390/life12060838
Journal volume & issue
Vol. 12, no. 6
p. 838

Abstract

Read online

Previous studies have revealed that Candida albicans isolates involved in chronic vulvovaginal candidosis (cVVC) phenotypically express less virulent traits than clinical isolates involved in sporadic infections. In this study, we aimed to further explore this finding by studying the behaviour of those same clinical isolates in in-vitro models of infection. Eighteen clinical Candida albicans isolates were collected from women suffering sporadic (eight isolates) or chronic infections (ten isolates). Adhesion to HeLa cells (human cervical cancer epithelial cell line) and resistance to phagocytosis by RAW 264.7 cells (murine macrophages cell line) were tested in-vitro. In addition, phenotypic expression of virulence factors related with either adhesion or resistance to phagocytosis was tested in-vitro. Results indicated that yeast isolates involved in sporadic infection adhered in a higher proportion of HeLa cells than those of chronic infections, which was related with their ability to produce biofilm (p p p < 0.05). We conclude that the evasion of macrophage-mediated phagocytosis related to the production of proteases might be an important factor involved in the recurrence of vulvovaginal candidosis infection.

Keywords